Therefore, Sesn2 can activate downstream AMPK and inhibit mTOR signal to induce autophagy, so as to regulate the occurrence and development of cardiovascular diseases, suggesting that Sesn2 may be a pharmacological target for treating cardiovascular diseases. Here, SESN2 is linked to cardiovascular disorder.